Market by Product, Application, Source Type, and Country | Forecast 2021-2028
As per Triton’s report, the biosurgery market in Europe is estimated to observe growth at a CAGR of 5.88% during the projected phase of 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries studied in this market comprise:
• The United Kingdom
• Spain
• Germany
• Italy
• France
• Russia
• Rest of Europe
Several
prominent factors, such as the rise in the adoption of new surgical products
and growth in the number of surgeries, are advancing the progression of the
biosurgery market across the region. Furthermore, the surge in chronic diseases
and longer stays in hospitals have stimulated the demand for biosurgery
products, which will further add to the growth of the biosurgery market within
Europe.
For
instance, the demand for biosurgery products is relatively high in Germany as
they offer various benefits, including high efficiency, user-friendliness, and
cost-effectiveness. Moreover, products that help in fast healing, preventing
scarring, add to the high demand. Furthermore, among various surgical
procedures, breast augmentation and liposuction are estimated to increase in
the next few years. Additionally, the growth in the geriatric population will
increase the demand for biosurgery devices. Therefore, as mentioned above, all
these factors expand the development of the biosurgery market within Germany.
In
the United Kingdom, the high prevalence of diabetes and cardiovascular
diseases, coupled with technological enhancements, adds to the studied market’s
growth. This increase is mainly due to the rise in sedentary lifestyles,
leading to increased wound-related complications during surgery. This increases
the demand for biosurgery products, thereby driving the growth of the
biosurgery market across the country.
Sanofi
is a pharmaceutical company engaged in developing, manufacturing, and marketing
healthcare products. The company provides various products related to rare
diseases, multiple sclerosis, oncology, diabetes, and cardiovascular diseases.
Besides, it develops combination drugs for treatments and biologics to produce
precision drugs through its R&D sector. Its product portfolio includes
SYNVISC, a viscosupplement injection that transfers fluid to the knew to help
lubricate the joints, relieving pain. Sanofi has operations across multiple
regions, with headquarters in France.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
BIOSURGERY MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON BIOSURGERY MARKET
2.2. TRENDS
IN BIOSURGERY TECHNOLOGY
2.3. KEY
INSIGHTS
2.4. PORTER’S
FIVE FORCES MODEL
2.4.1. THREAT
OF NEW ENTRANTS
2.4.2. THREAT
OF SUBSTITUTE PRODUCTS
2.4.3. BARGAINING
POWER OF BUYERS
2.4.4. BARGAINING
POWER OF SUPPLIERS
2.4.5. COMPETITIVE
RIVALRY
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. KEY
BUYING OUTLOOK
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
AND PARTNERSHIPS
2.8.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.8.3. ACQUISITIONS
& MERGERS
2.8.4. NEW
PRODUCT LAUNCHES & DEVELOPMENTS
2.9. MARKET
DRIVERS
2.9.1. GROWING
AGING POPULATION
2.9.2. TECHNOLOGICAL
ADVANCEMENTS AND INNOVATIONS IN HEALTHCARE FACILITIES
2.9.3. SURGE
IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS
2.9.4. PREVALENCE
OF SPINAL FUSION AND JOINT RECONSTRUCTION
2.9.5. STRONG
FOCUS ON RESEARCH AND DEVELOPMENT
2.10. MARKET
CHALLENGES
2.10.1. HIGH
COST OF SURGERIES
2.10.2. COMPLICATIONS
RELATED TO IMMUNE RESPONSE
2.10.3. USAGE
OF MINIMALLY INVASIVE SURGERIES
2.11. MARKET
OPPORTUNITIES
2.11.1. RESEARCH
AND INVESTMENTS IN BIOENGINEERING
2.11.2. DEVELOPMENT
OF POLICIES FOR REIMBURSEMENT AND COMPENSATION
3. EUROPE
BIOSURGERY MARKET – BY PRODUCT
3.1. HEMOSTATIC
AGENTS
3.2. BONE-GRAFT
SUBSTITUTES
3.2.1. SYNTHETIC
GRAFT EXTENDERS
3.2.2. DEMINERALIZED
BONE MATRIX
3.2.3. BONE
MORPHOGENETIC PROTEINS
3.2.4. CELL-BASED
MATRICES
3.3. SURGICAL
SEALING AGENTS
3.3.1. NATURAL
3.3.2. SYNTHETIC
3.4. SOFT-TISSUE
MANAGEMENT
3.4.1. SYNTHETIC
MESH/PATCH
3.4.2. NATURAL
MESH/PATCH
3.5. ANTI-ADHESIVE
AGENTS
3.6. STAPLE
LINE REINFORCEMENT
4. EUROPE
BIOSURGERY MARKET - BY APPLICATION
4.1. ORTHOPEDIC
SURGERY
4.2. CARDIO
AND THORACIC SURGERY
4.3. NEURO
AND SPINE SURGERY
4.4. GENERAL
SURGERY
4.5. OTHER
APPLICATIONS
5. EUROPE
BIOSURGERY MARKET – BY SOURCE TYPE
5.1. NATURAL
5.2. SYNTHETIC
6. EUROPE
BIOSURGERY MARKET – COUNTRY OUTLOOK
6.1. COUNTRY
ANALYSIS
6.1.1. GERMANY
6.1.2. UNITED
KINGDOM
6.1.3. FRANCE
6.1.4. ITALY
6.1.5. SPAIN
6.1.6. RUSSIA
6.1.7. REST
OF EUROPE
7. COMPETITIVE
LANDSCAPE
7.1. BAXTER
INTERNATIONAL INC
7.2. BECTON,
DICKINSON AND COMPANY
7.3. B
BRAUN MELSUNGEN AG
7.4. CSL
LIMITED
7.5. ETHICON
INC (JOHNSON & JOHNSON)
7.6. INTEGRA
LIFESCIENCES HOLDINGS CORPORATION
7.7. MEDTRONIC
PLC
7.8. RTI
SURGICAL
7.9. SANOFI
7.10. SMITH
& NEPHEW PLC
7.11. STRYKER
CORPORATION
7.12. WRIGHT
MEDICAL GROUP NV
7.13. ZIMMER
BIOMET HOLDINGS INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: EUROPE BIOSURGERY
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND
PARTNERSHIPS
TABLE 4: BUSINESS EXPANSIONS,
ANNOUNCEMENTS, & DIVESTITURES
TABLE 5: ACQUISITIONS &
MERGERS
TABLE 6: NEW PRODUCT LAUNCHES
& DEVELOPMENTS
TABLE 7: EUROPE BIOSURGERY
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE BONE-GRAFT
SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE SURGICAL
SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE SOFT-TISSUE
MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 11: EUROPE BIOSURGERY
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 12: EUROPE BIOSURGERY
MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)
TABLE 13: EUROPE BIOSURGERY
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: EUROPE BIOSURGERY
MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: EUROPE BIOSURGERY
MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 3: EUROPE BIOSURGERY
MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 4: EUROPE BIOSURGERY
MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 5: EUROPE BONE-GRAFT
SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $ MILLION)
FIGURE 6: EUROPE BONE-GRAFT
SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $ MILLION)
FIGURE 7: EUROPE BONE-GRAFT
SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $ MILLION)
FIGURE 8: EUROPE BONE-GRAFT
SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE BIOSURGERY
MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE SURGICAL SEALING
AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 11: EUROPE SURGICAL SEALING
AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 12: EUROPE BIOSURGERY
MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE SOFT-TISSUE
MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 14: EUROPE SOFT-TISSUE
MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 15: EUROPE BIOSURGERY MARKET,
BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE BIOSURGERY
MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)
FIGURE 17: EUROPE BIOSURGERY
MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 18: EUROPE BIOSURGERY
MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 19: EUROPE BIOSURGERY
MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 20: EUROPE BIOSURGERY
MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 21: EUROPE BIOSURGERY
MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 22: EUROPE BIOSURGERY
MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 23: EUROPE BIOSURGERY
MARKET, BY SOURCE TYPE, 2020 & 2028, (IN %)
FIGURE 24: EUROPE BIOSURGERY MARKET,
BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 25: EUROPE BIOSURGERY
MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 26: GERMANY BIOSURGERY
MARKET, 2021-2028 (IN $ MILLION)
FIGURE 27: UNITED KINGDOM
BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 28: FRANCE BIOSURGERY
MARKET, 2021-2028 (IN $ MILLION)
FIGURE 29: ITALY BIOSURGERY MARKET,
2021-2028 (IN $ MILLION)
FIGURE 30: SPAIN BIOSURGERY MARKET,
2021-2028 (IN $ MILLION)
FIGURE 31: RUSSIA BIOSURGERY
MARKET, 2021-2028 (IN $ MILLION)
FIGURE 32: REST OF EUROPE
BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)